Moreover, the fact that prolonged effects of HDACi were observed months after cessation of the 2-week treatment of young mice, suggests that the treatment eradicated a transient early developmental progenitor cell or even early transformed lymphoma stem cells [55], which would normally give rise to NPM::ALK lymphoma. The gene discussed is ALK; the disease is lymphoma.